Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06630845
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
Comparison of Whole Body DWI to FDG PET
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of Whole Body DWI to FDG PET Using PETMRI
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single arm prospective trial that evaluates whole body diffusion weight imaging DWI compared to 18F-fludeoxyglucose FDG Positron Emission Tomography with Magnetic resonance imaging PETMRI in participants with known metastatic cancer
Detailed Description:
PRIMARY OBJECTIVE
I Correlation of DWI and FDG to detect disease
SECONDARY OBJECTIVE
I Inter-reader variability of DWI interpretation by region
OUTLINE
Participants will be imaged at a single timepoint using whole body DWI concurrent with FDG PETMRI within 60 days of receiving a non-FDG PET either PETCT or PETMRI There will be an optional PETMRI performed within six months of the original study Participants will be followed up through a medical records review for up to two years
I Correlation of DWI and FDG to detect disease
SECONDARY OBJECTIVE
I Inter-reader variability of DWI interpretation by region
OUTLINE
Participants will be imaged at a single timepoint using whole body DWI concurrent with FDG PETMRI within 60 days of receiving a non-FDG PET either PETCT or PETMRI There will be an optional PETMRI performed within six months of the original study Participants will be followed up through a medical records review for up to two years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None